DaiChiharaMDPhD

Oncology • Houston, TX

Hematologic Oncology

Assistant Professor

Join to view full profile

Dr. Chihara is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chihara's full profile

Already have an account?

Office
1515 Holcombe Blvd
Unit 429
Houston, TX 77030
Phone+1 713-792-2121

Summary

Dr. Dai Chihara is an oncologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from Kobe University Faculty of Medicine and has been in practice 18 years. He specializes in lymphoma. He has more than 100 publications and over 2000 citings.

Education & Training

National Institutes of Health Clinical CenterFellowship, Medical Oncology, 2018 - 2020
University of New Mexico School of MedicineResidency, Internal Medicine, 2016 - 2018
Kobe Univ- Fac MedClass of 2004
Nagoya UniversityPh.D.

Certifications & Licensure

FL State Medical License 2021 - Present
TN State Medical License 2022 - 2026
AL State Medical License 2022 - 2025
AZ State Medical License 2022 - 2025
GA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025
OK State Medical License 2022 - 2025
TX State Medical License 2020 - 2025
WA State Medical License 2022 - 2025
LA State Medical License 2022 - 2024
DC State Medical License 2018 - 2022
NM State Medical License 2016 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

Abstract achievement award ASH, 2020
Outstanding Academic Achievement Award National Cancer Institute, 2020
Bradley Stuart Beller Endowed Merit Award American Society of Clinical Oncology, 2019
House Officer Research Award University of New Mexico, 2018
Next Generation Leadership Award naisA, 2018
Abstract achievement award American Society of Hematology, 2017
Fellow excellence award for professionalism MD Anderson Cancer Center, 2016
Best research fellow in Leukemia MD Anderson Cancer Center, 2016
The Kimberly Patterson fellowship in Leukemia research MD Anderson Cancer Center, 2016
The Janice Davis Singletary Lymphoma fellowship award MD Anderson Cancer Center, 2015
ASCO Merit award American Society of Clinical Oncology, 2015
ASH abstract achievement award American Society of Hematology, 2010, 2015
PanPacific Lymphoma Conference travel award PanPacific Lymphoma Conference, 2014
Young Investigators Award Japanese Society of Hematology, 2013
12th International Conference of Malignant Lymphoma travel award ICML, 2013
Join now to see all

Publications & Presentations

PubMed

Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature.
Côme Bommier, Brian K Link, Brianna J Gysbers, Matthew J Maurer, Melissa C Larson
Blood Advances. 2024-12-10
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung.
Susan Y Wu, Penny Q Fang, Ahmed Fetooh, Gohar S Manzar, Kelsey L Corrigan
Advances in Radiation Oncology. 2024-12-01
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium.
Jonathan R Day, Melissa C Larson, Urshila Durani, Jean L Koff, Yucai Wang
Blood Advances. 2024-11-27

Lectures

Randomized phase II study of cladribine with simultaneous or delayed rituximab in patients with untreated hairy cell leukemia.
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019